Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Microalgae in modern cancer therapy: Current knowledge
2018 Standout
Optical coherence tomography angiography
2017 Standout
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
2007 Standout
Targeted therapy of thyroid cancer
2010
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells
2011 StandoutNobel
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Italian consensus for the classification and reporting of thyroid cytology
2014 Standout
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Use of comprehensive geriatric assessment in older cancer patients:
2005
Amino-acid substitution in α-spectrin commonly coinherited with nondominant hereditary spherocytosis
1997 StandoutNobel
Thyroid cancer
2016 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?
2014
Myocardial Protection with Red Wine Extract
2000
The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury
1999
Angioid Streaks in Sickle-Thalassemia
1994
A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)
2009
A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis.
1996
Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer
2012
Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
2010
Membrane Dynamics of the Water Transport Protein Aquaporin-1 in Intact Human Red Cells
1999 StandoutNobel
Humic acid–mediated oxidative damages to human erythrocytes:
1999
Thyroid Gland Malignancies
2015
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Humic acids: Structural properties and multiple functionalities for novel technological developments
2015 Standout
The use of combinations of monoclonal antibodies in clinical oncology
2015
Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: Progress, pitfalls, and prospects
2007
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Pretreatment haematological laboratory values predict for excessive myelosuppression in patients receiving adjuvant FEC chemotherapy for breast cancer
2008
High-Resolution Microtubule Structures Reveal the Structural Transitions in αβ-Tubulin upon GTP Hydrolysis
2014 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Validation of the peroxidative indicators, cis-parinaric acid and parinaroyl-phospholipids, in a model system and cultured cardiac myocytes
1999
DNA repair dysregulation from cancer driver to therapeutic target
2012
New therapeutic advances in the management of progressive thyroid cancer
2009
Fluorescence probes used for detection of reactive oxygen species
2005 Standout
Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
2011
Approach to the Patient with Anaplastic Thyroid Carcinoma
2012
Duplication of 10 nucleotides in the erythroid band 3 (AE1) gene in a kindred with hereditary spherocytosis and band 3 protein deficiency (band 3PRAGUE).
1994
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO ANGIOID STREAKS
2013
A Fluorometric Method for Measurement of Oxygen Radical-Scavenging Activity of Water-Soluble Antioxidants
2000
Myocardial protection by Protykin, a novel extract oftrans-resveratrol and emodin
2000
Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis
2013
ROS and the DNA damage response in cancer
2018 Standout
C11-BODIPY581/591, an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology
2002
Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents
2015
Reconciling the chemistry and biology of reactive oxygen species
2008 Standout
Frailty in elderly people
2013 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Taekwondo training improves sensory organization and balance control in children with developmental coordination disorder: A randomized controlled trial
2011 Standout
Estimation of lipid peroxidation of live cells using a fluorescent probe, Diphenyl-1-pyrenylphosphine
2001
The Mass Production of Redundant, Misleading, and Conflicted Systematic Reviews and Meta‐analyses
2016 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer
2016
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
PlantL-ascorbic acid: chemistry, function, metabolism, bioavailability and effects of processing
2000 Standout
Investigation of polymer electrolyte membrane chemical degradation and degradation mitigation using in situ fluorescence spectroscopy
2012
Vitamin C: prospective functional markers for defining optimal nutritional status
1999
New Insights into Perfluorinated Sulfonic-Acid Ionomers
2017 Standout
Marine natural products
2015 Standout
Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
2007
Properties of Resveratrol:In VitroandIn VivoStudies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
2015 Standout
Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo
2008 Standout
Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase–Rearranged Anaplastic Thyroid Carcinoma
2014
Potentiation of the activity of cisplatin in a human colon tumour xenograft model by auristatin PYE, a structural modification of dolastatin 10
2010
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
BODIPY Dyes and Their Derivatives: Syntheses and Spectroscopic Properties
2007 Standout
Environmental Implications of Hydroxyl Radicals (•OH)
2015 Standout
Vestibular rehabilitation – For whom and how? A systematic review
2007
Natural product and natural product derived drugs in clinical trials
2014 Standout
Cardiac involvement in thalassemia intermedia: a multicenter study
2001
Risk Models for Predicting Chemotherapy-Induced Neutropenia
2005
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Evaluation of meta‐analyses in the otolaryngological literature
2008
Improving prediction of malignancy of cytologically indeterminate thyroid nodules
2009
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Kinase Inhibitors of Marine Origin
2013
Guidelines for the management of thyroid cancer
2014 Standout
Drug Resistance in Cancer: An Overview
2014 Standout
Near-infrared fluorophores for biomedical imaging
2017 Standout
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Lysyl Oxidase: From Basic Science to Future Cancer Treatment
2012
Works of P. Savvides being referenced
Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
2011
Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis
1993
Novel Fluorescein-Based Flow-Cytometric Method For Detection of Lipid Peroxidation
1997
Molecular Classification of Thyroid Nodules by Cytology
2008
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors
2009
Pseudoxanthoma elasticum‐like skin lesions and angioid streaks in β‐thalassemia
1992
Fluoresceinated phosphoethanolamine for flow-cytometric measurement of lipid peroxidation
1998
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
2012
Canalith Repositioning for Benign Paroxysmal Positional Vertigo
2005
Angioid Streaks in Homozygous β Thalassemia
1989
Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factors
2003
A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome
2009
Phase II Trial of Sorafenib in Patients with Advanced Anaplastic Carcinoma of the Thyroid
2012
Final results from a phase I study of oral TRC102 (methoxyamine HCl), an inhibitor of base-excision repair, to potentiate the activity of pemetrexed in patients with refractory cancer.
2010
Phase II trial of sorafenib (bay 43–9006) in patients with advanced anaplastic carcinoma of the thyroid (ATC)
2009
Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis
1993
Phase I study of the EGFR tyrosine kinase inhibitor erlotinib in combination with docetaxel and radiation in locally advanced squamous cell cancer of the head and neck (SCCHN)
2006
Phase II study of combretastatin A4 phosphate (CA4P) in patients with advanced anaplastic thyroid carcinoma (ATC)
2006
Cancer in the elderly.
2006